Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results

Rhea-AI Summary

Harmony Biosciences (Nasdaq: HRMY) announced it will release its fourth quarter and full year 2020 financial results on March 25, 2021 at 8:00 a.m. ET. A conference call will follow at 8:30 a.m. ET, providing insights into the company's performance in the past year. Investors can dial in or access the live webcast on their investor page. A replay will be available within 24 hours. This financial update is crucial for stakeholders tracking the company’s growth in the pharmaceutical sector focusing on rare neurological disorders.

Positive

• Scheduled financial results release on March 25, 2021 indicates planned transparency with investors.
• Conducting a conference call for stakeholders showcases commitment to investor relations.

Negative

• None.

PLYMOUTH MEETING, Pa., March 4, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced that it will issue a press release on the Company's fourth quarter and full year 2020 financial results on Thursday, March 25, 2021 at 8:00 a.m. ET. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET.

To participate in the call, please dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international), and reference passcode 5049024. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replayed webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

A replay of the call will be available within 24 hours by dialing (855) 859-2056 (domestic) or +1 (404) 537-3406 (international) and entering conference ID: 5049024. The replay will be available until April 1, 2021.

About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare, neurological disorders who have unmet medical needs. For more information on Harmony Biosciences, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Lisa Caperelli
610-608-0215
lcaperelli@harmonybiosciences.com

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/harmony-biosciences-announces-date-of-fourth-quarter-and-full-year-2020-financial-results-301240129.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences report its Q4 and full year 2020 results?

Harmony Biosciences will report its Q4 and full year 2020 results on March 25, 2021.

What time is the Harmony Biosciences conference call?

The conference call will take place at 8:30 a.m. ET on March 25, 2021.

How can I access the Harmony Biosciences financial results webcast?

The webcast can be accessed on the investor page of Harmony Biosciences' website.

Is there a replay available for the Harmony Biosciences conference call?

Yes, a replay will be available within 24 hours of the call.

Who should I contact for investor inquiries at Harmony Biosciences?

For investor inquiries, you can contact Lisa Caperelli at 610-608-0215.